Skip to main content

Bioasis Technologies Inc(BTI-X)
TSX Venture

Today's Change
Delayed Last Update

Bioasis Technologies: Bottom 25 Performing Stocks Year-to-Date on TSX-V (BTI)

The Globe and Mail - Thu Feb 16, 2023
Top 25 Stock Decliners Year to Date

Bioasis Technologies is among the group of bottom performing stocks year-to-date on the TSX Venture Exchange. This means each stock on this list has seen its share price decrease at a faster rate than the rest of the market so far this year.

This report is generated monthly. It highlights the 25 companies with the greatest percentage decrease in share price year-to-date. Stocks in this category are generally sold to preserve capital or held for speculation. Companies experiencing dramatic increases in share price can do so for a variety of reasons – including bearish changes in sector outlook, or the company is experiencing financial difficulties generally due to an inability to service its debt.

Symbol

Name

Period

Total Return

SN-XSennen Potash CorpYTD-64.444
AIR-XClean Air Metals IncYTD-65.385
KES-XKesselrun Resources LtdYTD-50
HCO-P-XHansco Capital CorpYTD-71.429
BTI-XBioasis Technologies IncYTD-50
ESTW-XEasTower Wireless IncYTD-50
EFV-XEF EnergyFunders Ventures IncYTD-50
CBAR-P-XCastlebar Capital CorpYTD-68.421
PNN-XPambili Natural Resources CorpYTD-50
WRR-XWalker River Resources CorpYTD-44.578
FREQ-XFrequency Exchange CorpYTD-55
PTP-H-XPetrichor Energy IncYTD-50
AIME-P-XAIM5 Ventures IncYTD-45.161
KAC-P-XKalon Acquisition CorpYTD-58.333
MKT-XDeepMarkit CorpYTD-57.143
DPCC-P-XDeal Pro Capital CorpYTD-56.667
PUC-XPancontinental Resources CorpYTD-44.444
SAI-H-XSunshine Agri-Tech IncYTD-50
BOCA-XBocana Resources CorpYTD-63.79
PTN-P-XProton Capital CorpYTD-58.333
ENA-XEnablence Technologies IncYTD-44.444
HRC-P-XHoshi Resource CorpYTD-60
SKP-XStrikepoint Gold IncYTD-50
CMO-H-XCliffmont Resources LtdYTD-55.556
ITG-H-XIntact Gold CorpYTD-50

More about Bioasis Technologies Inc

Bioasis Technologies Inc is a biopharmaceutical company developing xB3, a proprietary technology for the delivery of therapeutics across the blood-brain barrier and the treatment of CNS disorders, including brain cancers and neurodegenerative diseases.

Artificial intelligence at Report on Business

Report on Business scans market data using algorithms to process large quantities of information. The results are specialized reports produced through automation. Ongoing ROB project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities.

More from The Globe